chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 5/15/00, the pt received her 1st Lymerix shot with no reported events. On 6/15/00, 2 to 3 hours, post vax, the pt had severe nausea and vomiting, a feeling of generalized weakness and "needed to sleep." She reported "feeling funny" until she went to sleep. The responsible physician initially reported that the symptoms were attributed to a dystonic reaction; however, this dx was not confirmed on follow-up. The events resolved after the vaccinee vomited and rested.
Patient began with hives and itching all over. Patient given 50mg IM Benadryl Patient watched for 40 minutes. All sx improved.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 4:15 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 4:08 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 27.52 for dose administered on 02-Mar-2021 and 27.60 for dose administered on 30-Mar-2021.  No concomitant medications were reported.  Batch number 019B21A underwent temperature excursion on 30-Mar-2021 with temperature 33 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 30-Mar-2021.  Batch number 014M20A underwent temperature excursion on 02-Mar-2021 with temperature 27 degrees Fahrenheit at 09:00 AM, 29 degrees at 10:00 AM, 32 degrees at 11:00 AM, 33 degrees at 12:00 PM, 35 degrees at 02:00 PM and 36 degrees at 03:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 02-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Racing heart, blood pressure drops feel clammy. 2 severe events many smaller events. Heart rate gets to near 100. My idle heart rate is in the mid 50's.
Around 1520 patient was standing with brother against the wall waiting for mom to finish in bathroom. Both gave staff a high 5 and about 5 seconds later patient fell and hit his head on opposite wall. Patient was carried back to room 3 and Dr rushed in to exam him. Syncopal event shortly after receiving vaccines.
Patient's arm was very swollen and red the next day, went from just below shoulder to just above elbow, was also warm to the touch. It also hurt to touch.
Swelling red ball under skin @ injection site that is painful  DX: Cellulitis
This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 66-year-old female patient who received SHINGRIX (batch number 759E9, expiry date 25th April 2020) for prophylaxis. On 16th July 2018, the patient received the 2nd dose of SHINGRIX. On 16th July 2018, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details reported as follows: The healthcare professional reported that the patient had flu-like symptoms after receiving SHINGRIX on left arm. This case has been linked with US2018128734, reported by same reporter.
dx w/chronic inflammatory demyelinating polyneuropathy (CIDP);first sx 1mo-6wk p/vax begin w/gradual weakness to paralysis in arms, fingers then descending into legs;recv 2 series of hep b- p/1st non responder
This spontaneous report as received from nurse refers to currently 75 year old male patient with a concurrent history of cigarette smoking. Approximately in 2005 (when he was 68) the patient was vaccinated with PNEUMOVAX23 (lot number, route and dose not provided). No other co-suspects were reported. No concomitant medications were reported. Since that dose of PNEUMOVAX23 the patient experienced multiple bouts of pneumonia and severe bronchitis. He was treated with antibiotics. On an unknown date the patient recovered. The patient had been seen in the office. The relatedness for multiple bouts of pneumonia and severe bronchitis was not provided for PNEUMOVAX23. Additional information has been requested.
Red, swollen, knot.  Right thigh.  child warm to touch. Hasn't checked temperature.  Injection site looks like a spider bite.
SWEATING; EYES TEARING UP; UNCONTROLLABLE CHILLS; MUSCLE WEAKNESS; HEADACHE; FEVER; EXHAUSTION; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 30-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced sweating, eyes tearing up, uncontrollable chills, muscle weakness, headache, fever, and exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, sweating, uncontrollable chills, eyes tearing up, headache, muscle weakness and exhaustion was not reported. This report was non-serious.
Started losing my hair in patches after the second shot and after the booster. Am currently working with a dermatologist who started having me use a steroid foam, dandruff shampoo, and gave me a steroid shot in one of the bald spots. The first bald spot is starting to grow back slowly. The second bald spot has just started and there is no new growth yet.
Fever, involuntary shivers, aching joints, extremely painful arm (difficult to move).
He started to get chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (He started to get chills) and PYREXIA (Fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 048B21A) for COVID-19 vaccination.     no medical history was provided by the reporter.  Concomitant products included FISH OIL, AMLODIPINE, POTASSIUM, METOPROLOL, HYDROCORTISONE and OMEPRAZOLE for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (He started to get chills) and PYREXIA (Fever). At the time of the report, CHILLS (He started to get chills) and PYREXIA (Fever) outcome was unknown.            Treatment details included Tylenol. Action taken with mRNA-1273 in response to the event was not applicable.
Increased heart rate; Blurred vision; Panic; a feeling of adrenaline rushing through my body; a feeling of adrenaline rushing through my body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Sep2021 17:15 (Lot number: FF2587) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Food allergy onion" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Sleep apnea" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Tetracyclines, reaction(s): "Medication allergy tetracyclines", notes: Medication allergy tetracyclines, paraxetine, hydrocodone; Hydrocodone, reaction(s): "Medication allergy Hydrocodone"; Paraxetine, reaction(s): "Medication allergy paraxetine". The following information was reported: HEART RATE INCREASED (non-serious) with onset 23Sep2021 17:15, outcome "recovering", described as "Increased heart rate"; VISION BLURRED (non-serious) with onset 23Sep2021 17:15, outcome "recovering", described as "Blurred vision"; PANIC ATTACK (non-serious) with onset 23Sep2021 17:15, outcome "recovering", described as "Panic"; AGITATION (non-serious), ENERGY INCREASED (non-serious) all with onset 23Sep2021 17:15, outcome "recovering" and all described as "a feeling of adrenaline rushing through my body". Therapeutic measures were not taken as a result of heart rate increased, vision blurred, panic attack, agitation, energy increased.  Additional Information: The case reported as non-serious. Facility type vaccine was reported as Pharmacy or Drug Store. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. COVID prior vaccination was reported as no. COVID tested post vaccination reported as no.  Follow-up attempts are completed. No further information is expected.
Right thigh swelling and redness after shots. Shots given 03/09/05. Seen in ER 03/10/05. Followed up a clinic 03/11/05.
Chills headache fever 99.9 can't get up for over 20 minutes
Due to the Orilissa medication, I do not experience monthly menstruation. However, about 6 weeks after my vaccine dose from J&J, I experienced menstruation spotting for the first 2 - 3 days and then it turned into an irregular period. All-in-all, my period lasted about 8 days. Additionally, I experienced extreme cramping leading up to the irregular period due to the vaccine. No treatment was needed but I did consult with a doctor and they assured me that this is a none side effect.
Case previously recorded as MA2009-3747. Case received on 06 NOV 2009 from a consumer the following information: A 5-year-old male patient was vaccinated with H1N1 (manufacture and batch no. unknown), on an unknown date. The patient experienced the following day a swollen and red area around the shot, approx.2" circle. The outcome is unknown. The same reaction occurrs after the vaccination with seasonal Influenza vaccine, see case MA2009-3749.
left arm after one week began to itch, woke up today and arm is now red, hot and large Bump
flushing, macular rash of legs, arms, trunk 1hr p/vax given & 1hr following proventil for wheezing; no specific therapy; rash resolved in 2 days
FEELS ACHES AND PAINS; FEELING SICK TO STOMACH; FEELS LIKE GETTING A HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 01-JUN-2021 19:00 for prophylactic vaccination. No concomitant medications were reported. On 01-JUN-2021, the subject experienced feels aches and pains. On 01-JUN-2021, the subject experienced feeling sick to stomach. On 01-JUN-2021, the subject experienced feels like getting a headache. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from feeling sick to stomach, feels aches and pains, and feels like getting a headache. This report was non-serious.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with the improperly stored dose of RECOMBIVAX HB (strength reported as 5mcg/0.5ml, lot # M031574, expiration date 11-NOV-2018; dose and route of administration were not reported) for prophylaxis. The vaccine was improperly stored in the temperature from 47F to 77F for a few times, 5 hours in total. No adverse effects were reported. The call was made because of the data logger. Additional information has been requested.
Monday 10/4/10 2pm received flu shot arm throbbed immediately. Next day unable to lift left arm, site was red and hot lt shoulder x 3 days. Hurt with injection. Treated with Ibuprofen Mon and Tuesday.
Patient states he had his 1st moderna vaccine 2 weeks ago on March 16, 2021. His left arm was sore for 1 and half days and this has resolved.  He had some left groin pain shortly after this but this is gone Since the vaccine he has felt achy all over in his arms and legs He does not take a statin medication The last 3 days he has had neck pain on the left without radiation to his arms or associated numbness, weakness tingling or rash He denies any head trauma Patient works on a computer and has been blowing snow with a snow blower He denies any falls or trauma or new pillows He does not take any medications including over-the-counter herbs or other over-the-counter medications except for recently with his neck pain ibuprofen 2 pills every 4 hours He states heat does not help his neck and he cannot tolerate ice  He had 1 day of a fever up to 101 on March 27th but since has had temperatures of 98-99.  He denies constant shaking chills, ear pain, headache, cough, postnasal drainage, shortness of breath, wheezing, dyspnea on exertion, chest pain, UTI symptoms, change in sense of smell or taste He states his urine color changes from clear to yellow depending on how much he drinks Patient had a flu vaccine this year He has been very careful during COVID and has no known COVID exposures but would like to be tested for COVID
Red Rash; redness; swelling; a bit of sore arm; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a bit of sore arm), PAIN (Achiness), ERYTHEMA (redness), SWELLING (swelling) and RASH ERYTHEMATOUS (Red Rash) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K204 and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (a history of anaphylaxis reaction from bees). Concurrent medical conditions included Bee sting hypersensitivity.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (a bit of sore arm) and PAIN (Achiness). On 02-Feb-2021, the patient experienced ERYTHEMA (redness) and SWELLING (swelling). On 03-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. On 10-Feb-2021, RASH ERYTHEMATOUS (Red Rash) had resolved. At the time of the report, PAIN IN EXTREMITY (a bit of sore arm), PAIN (Achiness), ERYTHEMA (redness) and SWELLING (swelling) outcome was unknown.            Concomitant product use was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: Significant follow up received on 23-Apr-2021
This spontaneous report was received from a pharmacist refers to a 70 year old male patient. The patient's medical history were not reported. The patient's current condition included thyroid condition. On 06-SEP-2017, the patient was vaccinated with PNEUMOVAX 23 (Dosing details not reported) (lot # N003997, expiry date 20-SEP-2018) intramuscularly for prophylaxis. Concomitant therapy included levothyroxine sodium (Manufacturer unknown). The patient reports that he had no lab work done. On the same day, he took TYLENOL and put ice on the injection site. On 08-SEP-2017, redness appeared higher on the arm. On 09-SEP-2017, the swelling first appeared on the arm and the pharmacist reports that the injection site is fine now and the arm is swollen and she compared the arm in which the injection was given to the arm that did not have the injection and she reports that the arm is quite swollen. The patient reports that he has not used any treatment for the Peripheral swelling and has not contacted his doctor. The outcome of erythema was reported as recovered and the outcome of peripheral swelling was reported as not recovered.
Case previously recorded as MA2009-4221. Initial case report received from a physician via agency, on 11 NOV 2009. A patient, under the age of 4, was vaccinated with 0.25mL S-OIV FLUVIRIN (batch no. 102046P1) i.m. on 10 NOV 2009. No adverse event was reported. Agency reference no.: NA09-008010.
pt recvd vax & exp problems focusing w/eyes & w/night vision & memory;
She started shivering and she got goose bumps like cold, when you are cold; She started shivering and she got goose bumps like cold, when you are cold; I checked her neck and I realized she was hot; this morning she woke up 101.9; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the parent.  A 22 year-old female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: FF8841) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Sickle cell disease" (unspecified if ongoing), notes: Verbatim: Sickle cell disease; "Seizure" (unspecified if ongoing), notes: Verbatim: Seizures; "Asthmatic" (unspecified if ongoing), notes: Verbatim: Asthmatic. Concomitant medication(s) included: KEPPRA [LEVETIRACETAM] taken for seizure; SINGULAIR; QVAR; FOLIC ACID; ALAVERT; CALCIUM; ALBUTEROL [SALBUTAMOL]. Vaccination history included: Bnt162b2 (Dose: 1st), when the patient was 22 years old, for Covid-19 immunization; Bnt162b2 (Dose: 2nd), when the patient was 22 years old, for Covid-19 immunization. The following information was reported: CHILLS (non-serious), PILOERECTION (non-serious), outcome "unknown" and all described as "She started shivering and she got goose bumps like cold, when you are cold"; PYREXIA (non-serious), outcome "unknown", described as "I checked her neck and I realized she was hot; this morning she woke up 101.9". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional Information: The patient received Tylenol for pyrexia.  No follow-up attempts are possible. No further information is expected.
after about 12 hours had significant chills, fever, achey, tired, slight nausea.  Lasted about 12 hours.  nothing after second shot on 4/8/21
pt has concerns about her arm and "swelling" to the point she was unable to lift her arm in addition to a fever and exhaustion. Also, concerned about the fact she had Covid November of 2021 and worried if it added to her effects.
Angioedema congestion. Tingling sensation of face/lips. neck pain ("lump")  Narrative:  neck discomfort and "lump" to left side of neck 1/8/2021. Next day 01/09/2021, 4d post vaccine, tingling/burning sensation to lips along with lower lip swelling and slight nasal congestion. 1 week post vaccine 1/12/2021, continues with lower lip swelling with tingling sensation.
This spontaneous report as received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB, lot # L035878, expiration date 11-AUG-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of LIQUID PEDVAXHIB experienced the temperature excursion from 32 to 35 degrees Fahrenheit for 8 hours and form 47 to 77 degrees Fahrenheit for 8 hours. Data logger was not involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1707USA001092: US-009507513-1706USA010602: US-009507513-1707USA001091:
Hair loss.  Patient is currently being treated with minoxidil 2.5mg po daily.
felt like was going to pass out; became very cold; This is a spontaneous report from a contactable consumer or other non-health care professional. This consumer reporting for a female patient for a different event under the same suspect product for four patients. This is four of four reports. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH-COVID 19 Vaccine, solution for injection, Lot number was not reported), via an unspecified route of administration on 14Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 14Apr2021The patient experienced became very cold and felt like was going to pass out. She had to lay down after 10 minutes and EMT's were called, not sure of end result or any other information except she didn't eat today. The outcome of event was unknown.  Information about lot/Batch number has been requested.
received both shots): first - 1/9; second 1/30 normal arm soreness at first which went away; then yesterday woke up and the arm is very warm to the touch and red about 4in by 3in at the injection site; no symptoms at all after the first reaction
I had extreme abdominal pain that lasted about 5 hours.  It felt like every muscle in my abdomen was having the most intense Charlie horse I?ve ever had.  The pain was worse than when I dislocated my knee or fractured my ankle.  It was by far some of the worst pain I?ve ever experienced.  I considered going to the hospital but by the time I was able to move it started getting better.
3 days after receiving vaccine #1 I experienced: - Dizziness  - Very unbalanced when trying to stand or walk - Right side extremities hand, arm, leg, foot were numb with loss of sensitivity and strength
This spontaneous report as received from a pharmacist refers to a 70 year old patient. There was no information regarding to medical history/concurrent conditions and concomitant medication. On 12-JUN-2014 the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX lot # J000151, expiry date 07-JAN-2015, 0.5 ml, subcutaneous for chicken pox vaccine which was prescripted from unspecified physician. Pharmacist stated in contacting unspecified physician office for suggesting booster date for (Oka/Merck) VARIVAX, it was discovered ZOSTAVAX was the desired vaccine. No adverse effects reported. The outcome of event was not reported. Additional information has been requested.